1 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 1, Not yet recruiting 1, Recruiting 1, Unknown 1 |
Follow niraparib: new trials by email Literature Review of niraparib trials Research Report on niraparib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluating Safety, Tolerability, and Metabolism of Niraparib Niraparib - Ovarian Cancer | Phase 4 | Recruiting | University of Miami | 70 | 2026-07-28 | 2026-08-05 |
| A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer Niraparib - Ovarian Neoplasms | Phase 4 | Not yet recruiting | GlaxoSmithKline | 67 | 2025-04-22 | 2025-03-21 |
| PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer Niraparib - Epithelial Ovarian Cancer, Ovarian Cancer | Phase 4 | Unknown | Seoul National University Hospital | 102 | 2022-01-01 | 2022-01-26 |
| NIraparib and Quality of LifE is a Longitudinal Study Evaluating in Real Life the Tolerability of Niraparib. Niraparib - Ovarian Cancer | Phase 4 | Completed | ARCAGY/ GINECO GROUP | 141 | 2019-04-03 | 2024-12-13 |
Ovarian Neoplasms (4) · Carcinoma, Ovarian Epithelial (1)
ARCAGY/ GINECO GROUP (1) · GlaxoSmithKline (1) · Seoul National University Hospital (1) · University of Miami (1)
France (1) · Nigeria (1) · United States (1)
Jae-Weon Jae-Weon, MD, PhD (1) · Matthew Schlumbrecht, MD (1) · Sophia HL George, PhD (1)
2018 (1)